D
Dvora Nass
Researcher at Tel Aviv University
Publications - 7
Citations - 1340
Dvora Nass is an academic researcher from Tel Aviv University. The author has contributed to research in topics: Cancer & microRNA. The author has an hindex of 4, co-authored 7 publications receiving 1276 citations. Previous affiliations of Dvora Nass include Sheba Medical Center.
Papers
More filters
Journal ArticleDOI
MicroRNAs accurately identify cancer tissue origin
Nitzan Rosenfeld,Ranit Aharonov,Eti Meiri,Shai Rosenwald,Yael Spector,Merav Zepeniuk,Hila Benjamin,Norberto Shabes,Sarit Tabak,Asaf Levy,Danit Lebanony,Yaron Goren,Erez Silberschein,Nurit Targan,Alex Ben-Ari,Shlomit Gilad,Netta Sion-Vardy,Ana Tobar,Meora Feinmesser,Oleg Kharenko,Ofer Nativ,Dvora Nass,Dvora Nass,Marina Perelman,Marina Perelman,Ady Yosepovich,Ady Yosepovich,Bruria Shalmon,Bruria Shalmon,Sylvie Polak-Charcon,Sylvie Polak-Charcon,Eddie Fridman,Eddie Fridman,Amir Avniel,Isaac Bentwich,Zvi Bentwich,Dalia Cohen,Ayelet Chajut,Iris Barshack,Iris Barshack +39 more
TL;DR: The effectiveness of miRNAs as biomarkers for tracing the tissue of origin of cancers of unknown primary origin is demonstrated and the utility of the miRNA biomarkers by quantitative RT-PCR is validated.
Journal ArticleDOI
MiR-92b and miR-9/9* Are Specifically Expressed in Brain Primary Tumors and Can Be Used to Differentiate Primary from Metastatic Brain Tumors
Dvora Nass,Dvora Nass,Shai Rosenwald,Eti Meiri,Shlomit Gilad,Hilla Tabibian-Keissar,Anat Schlosberg,Hagit Kuker,Netta Sion-Vardy,Ana Tobar,Oleg Kharenko,Einat Sitbon,Gila Lithwick Yanai,Eran Elyakim,Hila Cholakh,Hadas Gibori,Yael Spector,Zvi Bentwich,Iris Barshack,Iris Barshack,Nitzan Rosenfeld +20 more
TL;DR: Using microRNA expression profiling, it is found that hsa‐miR‐92b and hsa-miR-9/hsa‐ MiR‐9* are over‐expressed, specifically in brain primary tumors, as compared to primary tumors from other tissues and their metastases to the brain.
Journal ArticleDOI
Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin
Shai Rosenwald,Shlomit Gilad,Sima Benjamin,Danit Lebanony,Nir Dromi,Alexander Faerman,Hila Benjamin,Ronen Tamir,Meital Ezagouri,Eran Goren,Iris Barshack,Iris Barshack,Dvora Nass,Dvora Nass,Ana Tobar,Ana Tobar,Meora Feinmesser,Meora Feinmesser,Nitzan Rosenfeld,Ilit Leizerman,Karin Ashkenazi,Yael Spector,Ayelet Chajut,Ranit Aharonov +23 more
TL;DR: A qRT–PCR test based on the expression profile of 48 tissue-specific microRNAs allows accurate identification of the tumor tissue of origin.
Journal ArticleDOI
Deleterious variants in TRAK1 disrupt mitochondrial movement and cause fatal encephalopathy.
Ortal Barel,May Christine V. Malicdan,Bruria Ben-Zeev,Bruria Ben-Zeev,Judith Kandel,Hadass Pri-Chen,Hadass Pri-Chen,Joshi Stephen,Inês G. Castro,Jeremy Metz,Osama Atawa,Sharon Moshkovitz,Esther Ganelin,Esther Ganelin,Iris Barshack,Iris Barshack,Sylvie Polak-Charcon,Sylvie Polak-Charcon,Dvora Nass,Dvora Nass,Dina Marek-Yagel,Dina Marek-Yagel,Ninette Amariglio,Nechama Shalva,Nechama Shalva,Thierry Vilboux,Thierry Vilboux,Carlos Ferreira,Ben Pode-Shakked,Ben Pode-Shakked,Gali Heimer,Gali Heimer,Chen Hoffmann,Chen Hoffmann,Tal Yardeni,Andreea Nissenkorn,Andreea Nissenkorn,Camila Avivi,Eran Eyal,Nitzan Kol,Efrat Glick Saar,Douglas C. Wallace,William A. Gahl,Gideon Rechavi,Gideon Rechavi,Michael Schrader,David M. Eckmann,Yair Anikster,Yair Anikster +48 more
TL;DR: The role of TRAK1 in mitochondrial dynamics is confirmed and constitutes the first report of this gene in association with a severe neurodevelopmental disorder.
Journal ArticleDOI
Radiation-induced vascular malformations in the brain, mimicking tumor in MRI-based treatment response assessment maps (TRAMs).
David Guez,Dianne Daniels,Shirley Sharabi,Dvora Nass,Dvora Nass,Ouzi Nissim,Roberto Spiegelmann,Roberto Spiegelmann,Galia Tzarfaty,Galia Tzarfaty,Chen Hoffmann,Chen Hoffmann,Alisa Talianski,Alisa Talianski,Yigal Shoshan,Yakov Fellig,Sagi Harnof,Sagi Harnof,Zvi R. Cohen,Zvi R. Cohen,Leor Zach,Leor Zach,Yael Mardor,Yael Mardor +23 more
TL;DR: Of 310 brain tumors patients recruited, histology of 99 lesions was available and 5 were histologically confirmed as radiation-induced malformations, but TRAMs cannot differentiate active tumor from vascular malformation.